AbolerIS Pharma

About:

AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.

Website: https://aboleris-pharma.com

Top Investors: SFPIM, Investsud, Criteria Venture Tech, Sham, Turenne Groupe

Description:

AbolerIS Pharma has a novel and distinct therapeutic approach that induces immune tolerance and preserves useful immune responses in inflammatory, autoimmune, and degenerative diseases, allowing researchers to concentrate on the development of novel drugs in areas of unmet medical need.